First-lineNovoRapid, Humulin I

Insulin (Aspart / Isophane)

Short- and intermediate-acting insulins

Mainstay for T1DM, severe GDM, and DKA in pregnancy.

SubcutaneousIV (DKA / labour)

First-line for

  • Type 1 DM in pregnancy
  • GDM not controlled on metformin
  • DKA in pregnancy

Mechanism

Activates insulin receptor → glucose uptake (muscle/fat), ↓ hepatic glucose output, ↓ lipolysis & ketogenesis.

“5.3 / 7.8” pregnancy targets

  • Fasting <5.3 mmol/L
  • 1 h post-meal <7.8 mmol/L
  • 2 h post-meal <6.4 mmol/L
  • Avoid <4 mmol/L (hypoglycaemia)

Dosing

Basal-bolus
Individualised; needs ↑ ~50% by T3
Sliding scale (labour)
Variable rate IV insulin + 10% dextrose
DKA
0.1 units/kg/h IV after fluid resuscitation

Contraindications

  • AbsoluteHypoglycaemia
  • CautionDrop dose 50% immediately postpartum to pre-pregnancy levels

Side effects

  • Hypoglycaemia
  • Weight gain
  • Lipohypertrophy at injection sites

Fetal & maternal notes

  • Does not cross placenta.
  • Tight glycaemic control reduces macrosomia, neonatal hypoglycaemia, stillbirth.

Key interactions

  • Betamethasone (lung maturation)

    Caution

    Hyperglycaemia 24–72 h — ↑ insulin requirement

  • Beta-blockers

    Caution

    Mask hypoglycaemia awareness

Clinical pearls

  • 💡 Always co-prescribe glucagon for severe hypo.
  • 💡 Pre-conception folic acid 5 mg + tight HbA1c <48 mmol/mol.

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.